November 1 2017, David R Brown
Safic-Alcan establishes a strategic alliance to supply pharmaceutical ingredients in Turkey
Safic-Alcan has announced the establishment of a strategic alliance with Marmara Ecza, a leading Turkish distributor specialised in the pharmaceutical sector. The company, which was founded in 1957, distributes excipients, APIs and specialty chemicals on behalf of a number of world leading producers including Evonik, Meggle and Blanver.
This partnership with Marmara will enable us to expand into the pharmaceutical sector in Turkey and to complement our fast growth in the regionYann Lissillour
Director of Mergers and Acquisitions for the Safic-Alcan Group
“This partnership with Marmara will enable us to expand into the pharmaceutical sector in Turkey and to complement our fast growth in the region”, stated Yann Lissillour, Director of Mergers and Acquisitions for the Safic-Alcan Group.
Marmara distributes a wide range of ingredients used in the pharmaceutical, cosmetic, OTC and veterinary medicinal industries from their own GDP certified warehouse located in Istanbul. The company will continue to be managed by Mr Okan Gozacan and Ms Tugce Gozacan. “Joining our forces will allow to strengthen our position on excipients and to access Safic-Alcan's expertise on active ingredients”, added Mr and Ms Gozacan.
“This joint venture is in line with our strategy of global sector diversification and is a further step in bolstering our presence in Turkey, following the completion of the acquisition of Interplast in 2011”, said Philippe Combette, CEO of the Safic-Alcan Group.
Safic-Alcan is a leading, independent distributor of specialty chemicals headquartered in Paris-La Défense, France. The company supplies a wide range of polymers, materials and additives for the rubber, coatings, pharmaceuticals and cosmetics industries. The Group is present in all major countries of the European Union, as well as in Turkey, and China with on-going strategic development in Eastern European countries and the USA. In 2016, Safic-Alcan reported reveunes of EUR 508 million.
Source(s): Safic-Alcan Press Release